Paper40584
Effects of oral H1 and H2 receptor antagonists in asthma.
Leopold JD and 2 others. Br J Clin Pharmacol, 1979. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of oral H1 and H2 receptor antagonists in asthma. Papers, record 40584. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40584
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Histamine H1 Antagonists | Major topic |
| Histamine H2 Antagonists | Major topic |
| Adolescent | |
| Adult | |
| Double-Blind Method | |
| Forced Expiratory Flow Rates | |
| Humans | |
| Middle Aged | |
| Peak Expiratory Flow Rate | |
| Physical Exertion |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,145,535 | Comparison of the bronchial response to running and cycling in asthma using an improved definition of the response to work. | Thorax | 1975 | https://conductscience.org/library/papers/1145535 | PubMed |
| 2 | 13,094 | Bronchodilating activity of an H1 blocker, chlorpheniramine. | J Allergy Clin Immunol | 1977 | https://conductscience.org/library/papers/13094 | PubMed |
| 4 | 49,311 | Sequential analysis of the allergic response: cyclic AMP, calcium and histamine. | Int Arch Allergy Appl Immunol | 1975 | https://conductscience.org/library/papers/49311 | PubMed |
| 5 | 629,482 | H2 receptor mediated inhibition of immediate type hypersensitivity reactions in vivo. | Am Rev Respir Dis | 1978 | https://conductscience.org/library/papers/629482 | PubMed |
| 6 | 694,800 | Bronchodilatation after inhalation of the antihistamine clemastine. | Thorax | 1978 | https://conductscience.org/library/papers/694800 | PubMed |
| 7 | 915,147 | The relationship of plasma histamine to the activity of bronchial asthma. | J Allergy Clin Immunol | 1977 | https://conductscience.org/library/papers/915147 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,150,725 | H2-receptor blockade and exercise-induced asthma. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6150725 | PubMed |
| 6,127,438 | H1-receptor antagonists: comparative pharmacology and clinical use. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6127438 | PubMed |
| 3,899,673 | Protective effect by UCB JO28 against histamine and methacholine induced bronchial hyperreactivity. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3899673 | PubMed |
| 2,408,646 | Ranitidine does not potentiate mediator release from human lung in vitro. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/2408646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40584
GET https://conductscience.org/api/papers/v1/40584/authors